[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

BCG Vaccine-Europe Market Status and Trend Report 2013-2023

February 2018 | 141 pages | ID: B265A377951EN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

BCG Vaccine-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on BCG Vaccine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole Europe and Regional Market Size of BCG Vaccine 2013-2017, and development forecast 2018-2023
Main market players of BCG Vaccine in Europe, with company and product introduction, position in the BCG Vaccine market
Market status and development trend of BCG Vaccine by types and applications
Cost and profit status of BCG Vaccine, and marketing status
Market growth drivers and challenges

The report segments the Europe BCG Vaccine market as:

Europe BCG Vaccine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

Germany
United Kingdom
France
Italy
Spain
Benelux
Russia

Europe BCG Vaccine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Immune BCG
Therapy BCG

Europe BCG Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Hospitals
Clinics
Others

Europe BCG Vaccine Market: Players Segment Analysis (Company and Product introduction, BCG Vaccine Sales Volume, Revenue, Price and Gross Margin):

Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF BCG VACCINE

1.1 Definition of BCG Vaccine in This Report
1.2 Commercial Types of BCG Vaccine
  1.2.1 Immune BCG
  1.2.2 Therapy BCG
1.3 Downstream Application of BCG Vaccine
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 Development History of BCG Vaccine
1.5 Market Status and Trend of BCG Vaccine 2013-2023
  1.5.1 Europe BCG Vaccine Market Status and Trend 2013-2023
  1.5.2 Regional BCG Vaccine Market Status and Trend 2013-2023

CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of BCG Vaccine in Europe 2013-2017
2.2 Consumption Market of BCG Vaccine in Europe by Regions
  2.2.1 Consumption Volume of BCG Vaccine in Europe by Regions
  2.2.2 Revenue of BCG Vaccine in Europe by Regions
2.3 Market Analysis of BCG Vaccine in Europe by Regions
  2.3.1 Market Analysis of BCG Vaccine in Germany 2013-2017
  2.3.2 Market Analysis of BCG Vaccine in United Kingdom 2013-2017
  2.3.3 Market Analysis of BCG Vaccine in France 2013-2017
  2.3.4 Market Analysis of BCG Vaccine in Italy 2013-2017
  2.3.5 Market Analysis of BCG Vaccine in Spain 2013-2017
  2.3.6 Market Analysis of BCG Vaccine in Benelux 2013-2017
  2.3.7 Market Analysis of BCG Vaccine in Russia 2013-2017
2.4 Market Development Forecast of BCG Vaccine in Europe 2018-2023
  2.4.1 Market Development Forecast of BCG Vaccine in Europe 2018-2023
  2.4.2 Market Development Forecast of BCG Vaccine by Regions 2018-2023

CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES

3.1 Whole Europe Market Status by Types
  3.1.1 Consumption Volume of BCG Vaccine in Europe by Types
  3.1.2 Revenue of BCG Vaccine in Europe by Types
3.2 Europe Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Germany
  3.2.2 Market Status by Types in United Kingdom
  3.2.3 Market Status by Types in France
  3.2.4 Market Status by Types in Italy
  3.2.5 Market Status by Types in Spain
  3.2.6 Market Status by Types in Benelux
  3.2.7 Market Status by Types in Russia
3.3 Market Forecast of BCG Vaccine in Europe by Types

CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of BCG Vaccine in Europe by Downstream Industry
4.2 Demand Volume of BCG Vaccine by Downstream Industry in Major Countries
  4.2.1 Demand Volume of BCG Vaccine by Downstream Industry in Germany
  4.2.2 Demand Volume of BCG Vaccine by Downstream Industry in United Kingdom
  4.2.3 Demand Volume of BCG Vaccine by Downstream Industry in France
  4.2.4 Demand Volume of BCG Vaccine by Downstream Industry in Italy
  4.2.5 Demand Volume of BCG Vaccine by Downstream Industry in Spain
  4.2.6 Demand Volume of BCG Vaccine by Downstream Industry in Benelux
  4.2.7 Demand Volume of BCG Vaccine by Downstream Industry in Russia
4.3 Market Forecast of BCG Vaccine in Europe by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BCG VACCINE

5.1 Europe Economy Situation and Trend Overview
5.2 BCG Vaccine Downstream Industry Situation and Trend Overview

CHAPTER 6 BCG VACCINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE

6.1 Sales Volume of BCG Vaccine in Europe by Major Players
6.2 Revenue of BCG Vaccine in Europe by Major Players
6.3 Basic Information of BCG Vaccine by Major Players
  6.3.1 Headquarters Location and Established Time of BCG Vaccine Major Players
  6.3.2 Employees and Revenue Level of BCG Vaccine Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 BCG VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Merck
  7.1.1 Company profile
  7.1.2 Representative BCG Vaccine Product
  7.1.3 BCG Vaccine Sales, Revenue, Price and Gross Margin of Merck
7.2 Sanofi Pasteur
  7.2.1 Company profile
  7.2.2 Representative BCG Vaccine Product
  7.2.3 BCG Vaccine Sales, Revenue, Price and Gross Margin of Sanofi Pasteur
7.3 Japan BCG Lab
  7.3.1 Company profile
  7.3.2 Representative BCG Vaccine Product
  7.3.3 BCG Vaccine Sales, Revenue, Price and Gross Margin of Japan BCG Lab
7.4 China National Biotec
  7.4.1 Company profile
  7.4.2 Representative BCG Vaccine Product
  7.4.3 BCG Vaccine Sales, Revenue, Price and Gross Margin of China National Biotec
7.5 Serum Institute of India
  7.5.1 Company profile
  7.5.2 Representative BCG Vaccine Product
  7.5.3 BCG Vaccine Sales, Revenue, Price and Gross Margin of Serum Institute of India
7.6 Intervax
  7.6.1 Company profile
  7.6.2 Representative BCG Vaccine Product
  7.6.3 BCG Vaccine Sales, Revenue, Price and Gross Margin of Intervax
7.7 GSBPL
  7.7.1 Company profile
  7.7.2 Representative BCG Vaccine Product
  7.7.3 BCG Vaccine Sales, Revenue, Price and Gross Margin of GSBPL

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BCG VACCINE

8.1 Industry Chain of BCG Vaccine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BCG VACCINE

9.1 Cost Structure Analysis of BCG Vaccine
9.2 Raw Materials Cost Analysis of BCG Vaccine
9.3 Labor Cost Analysis of BCG Vaccine
9.4 Manufacturing Expenses Analysis of BCG Vaccine

CHAPTER 10 MARKETING STATUS ANALYSIS OF BCG VACCINE

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications